The Impact of Telemedicine on Parkinson’s Care during the COVID-19 Pandemic: An Italian Online Survey

Ruggiero, Fabiana; Lombi, Linda; Molisso, Maria Takeko; Fiore, Giorgio; Zirone, Eleonora; Ferrucci, Roberta; Pirola, Elena; Locatelli, Marco; Barbieri, S.; Mameli, Francesca

doi:10.3390/healthcare10061065

Cited by 5 publications

(6 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although telemedicine services are not superior to the in-person visits in providing care, a growing body of evidence suggests that it offers greater efficiency and service for PD patients [ 50 ]. An online survey in Italy has investigated the impact of COVID-19 on access to telehealth care among 197 PD patients and 42 neurologists [ 51 ]. The results showed that 37.6% of PD patients and 88.1% of neurologists had chosen alternatives to in-person visits, while 13.7% of PD patients and 40.5% of neurologists used telemedicine.…”

Section: Covid-19 and Pdmentioning

confidence: 99%

“…The results showed that 37.6% of PD patients and 88.1% of neurologists had chosen alternatives to in-person visits, while 13.7% of PD patients and 40.5% of neurologists used telemedicine. Most of them were satisfied with the use of telemedicine during the COVID-19 pandemic, indicating that telemedicine has the potential to improve the care for PD patients, especially when access to in-person visits is limited [ 51 ]. Another survey of 417 PD patients in Canada aiming to see the effects of confinement on patients’ daily living and disease management suggested that COVID-19-related confinement affected PD manifestation and management [ 52 ], and the patients reported varying levels of interest in continuing remote care via phone or video conference [ 52 ].…”

Section: Covid-19 and Pdmentioning

confidence: 99%

See 1 more Smart Citation

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms

Huang

Zhang

Tan

et al. 2023

Transl Neurodegener

View full text Add to dashboard Cite

The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with neurodegenerative diseases and the specific neurological manifestations of COVID-19 have aroused great interest. However, there are still many issues of concern to be clarified. Therefore, we review the current literature on the complex relationship between COVID-19 and neurodegenerative diseases with an emphasis on Parkinson’s disease (PD) and Alzheimer’s disease (AD). We summarize the impact of COVID-19 infection on symptom severity, disease progression, and mortality rate of PD and AD, and discuss whether COVID-19 infection could trigger PD and AD. In addition, the susceptibility to and the prognosis of COVID-19 in PD patients and AD patients are also included. In order to achieve better management of PD and AD patients, modifications of care strategies, specific drug therapies, and vaccines during the pandemic are also listed. At last, mechanisms underlying the link of COVID-19 with PD and AD are reviewed.

show abstract

Section: Covid-19 and Pdmentioning

confidence: 99%

Section: Covid-19 and Pdmentioning

confidence: 99%

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms

Huang

Zhang

Tan

et al. 2023

Transl Neurodegener

View full text Add to dashboard Cite

show abstract

“…Although not superior to in-person visits, a growing body of evidence suggests that telemedicine services offer greater efficiency for PD patients [ 26 ]. An online survey in Italy has investigated the impact of COVID-19 on the access to telehealth care among 197 PD patients and 42 neurologists [ 27 ]. The results showed that 37.6% of PD patients and 88.1% of neurologists had chosen alternatives to in-person visits, while 13.7% of PD patients and 40.5% of neurologists used telemedicine services.…”

Section: Discussionmentioning

confidence: 99%

Life and disease status of patients with Parkinson’s disease during and after zero-COVID in China: an online survey

Huang,

Tan,

Chen

et al. 2024

Transl Neurodegener

View full text Add to dashboard Cite

Background Little is known about the impact of the COVID-19 pandemic on patients with Parkinson’s disease (PD) at different stages of the pandemic. This study aims to assess the lives and disease status of PD patients during the zero-COVID policy period and after ending the zero-COVID policy. Methods This multicenter cross-sectional study included two online surveys among PD patients in China, from May 30 to June 30 in 2022 and from January 1 to February 28 in 2023, respectively. The survey questionnaires contained four sections: (1) status of COVID-19 infection; (2) impact on motor and non-motor symptoms; (3) impact on daily and social lives; and (4) impact on PD disease management. Results A total of 1764 PD patients participated in the first online survey, with 200 patients having lockdown experience and 3 being COVID-19-positive (0.17%). In addition, 537 patients participated in the second online survey, with 467 patients having COVID-19 infection (86.96%). (1) During zero-COVID, all of the COVID-19-positive patients had mild symptoms of COVID-19 and no death was reported. After zero-COVID, 83.51% of the COVID-19-positive patients had mild symptoms. The overall death rate and inpatient mortality rate of COVID-19-positive PD patients were 3.21% and 30.00%, respectively. (2) During zero-COVID, 49.43% of PD patients reported worsening of PD-related symptoms (lockdown vs. unlockdown, 60.50% vs. 48.02%, P = 0.0009). After zero-COVID, 54.93% of PD patients reported worsening of PD-related symptoms (COVID-19 positive vs. COVID-19 negative, 59.31% vs. 25.71%, P < 0.0001). (3) During zero-COVID, 62.36% of patients felt worried, and ‘limited outdoor activities’ (55.39%) was the top reason for mental health problems. After zero-COVID, 59.03% of patients felt worried, with ‘poor health’ (58.10%) being the top reason. The PD patients tended to change their daily activities from offline to online, and their economic and caregiver burdens increased both during and after zero-COVID. (4) Most PD patients would like to choose online rehabilitation during (69.56%) and after zero-COVID (69.27%). The demand for online medication purchasing also increased during (47.00%) and after zero-COVID (26.63%). Conclusions The COVID-19 pandemic aggravated the motor and non-motor symptoms of PD patients either during or after the zero-COVID policy period. The PD patients also experienced prominent mental health problems, changes in daily activities, and increases in economic and caregiver burdens. The COVID-19 pandemic has changed ways of PD management with increasing demands for online medication purchasing and rehabilitation.

show abstract

“… 7 , 32 Although usage drastically increased up to >90% in the United States, 8 , 11 , 12 , 33 , 34 implementation in Europe is lagging behind. Less than 15% of PwP in Italy 35 and Germany 9 , 36 were acquainted with video‐based consultations and less than two‐thirds of neurologists offered these services. 3 , 35 In contrast, ~50% of PwP in Germany 9 express demand for teleconsultations, with rising numbers over the development of the pandemic, as shown in this study.…”

Section: Discussionmentioning

confidence: 99%

Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives

Wolff

Haller

Demleitner

et al. 2023

Movement Disord Clin Pract

View full text Add to dashboard Cite

Background The coronavirus disease 2019 (COVID‐19) pandemic has heavily impacted medical care of patients with Parkinson's disease (PwP). Objective To assess the longitudinal impact of the COVID‐19 pandemic on PwP and their relatives in Germany. Methods Two online, nationwide, cross‐sectional surveys were conducted from December 2020 to March 2021 and from July to September 2021. Results A total of 342 PwP and 113 relatives participated. Despite partial resumption of social and group activities, healthcare was continuously disrupted during times of loosened restrictions. Respondents’ willingness to use telehealth infrastructure increased, yet the availability remained low. PwP reported worsened symptoms and further deterioration during the pandemic, resulting in an increase in new symptoms and relatives’ burden. We identified patients at particular risk: young patients and those with long disease duration. Conclusions The COVID‐19 pandemic persistently disrupts the care and quality of life of PwP. Although willingness to use telemedicine services has increased, its availability needs to be improved.

show abstract

The Impact of Telemedicine on Parkinson’s Care during the COVID-19 Pandemic: An Italian Online Survey

Cited by 5 publications

References 22 publications

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms

Life and disease status of patients with Parkinson’s disease during and after zero-COVID in China: an online survey

Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives

Contact Info

Product

Resources

About